Search Medical Condition
Please enter condition
Please choose location
 

Migraine (Pediatric) Clinical Trials

A listing of Migraine (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (8) clinical trials

This study is testing an investigational medication for migraine headaches for pediatrics. Eligibility Criteria: -Ages 6 years to under 18 years -Diagnosis of migraines for at least 1 year -Experience 4 or more migraine days per month Other Details: Qualified volunteers will receive investigational study medication and study-related testing at ...

Phase

This study will be testing an investigational medication for migraine headaches for children. Eligibility Criteria: -Ages 6 years to 11 years -Diagnosis of migraine headaches for at least 6 months -Experience 2 or more migraine attacks per month -Other criteria may apply Other Details: Qualified volunteers receive investigational medication and ...

Phase

To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years. Eligibility Criteria: Each child must have a responsible trained adult with knowledge of the conduct of the study and must be available to supervise migraine ...

Phase

If the answer to this question is yes, and your child is 12-17 years of age, and experiences two or more migraine headaches a month, he or she may be eligible to join a clinical research study looking at an investigational treatment for migraine headaches. The study will involve 3-4 ...

Phase N/A

The objective of the study is to evaluate the safety and efficacy of ONZETRA Xsail (AVP-825) compared to placebo in the acute treatment of migraine in adolescent patients, 12 through 17 years of age.

Phase

Does your child get migraines? Your child may be eligible to participate in a migraine research study if they: -Are 6 to 11 years old -Have experienced migraines (with or without aura) for at least 6 months -Get at least 2 migraine attacks per month of moderate or severe intensity ...

Phase

Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine

The purpose of this study is to determine if there are significant differences in the side effects related to memory, repetition and recall among these three drugs when used in a pediatric population.

Phase N/A

Efficacy Safety and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (50 and 100 mg) compared to placebo for the acute treatment of a single migraine attack.

Phase